Matinas Biopharma Holdings Inc. (NYSE AMERICAN: MTNB) Stock Information | RedChip

Matinas Biopharma Holdings Inc. (NYSE AMERICAN: MTNB) Listen to this Section


$0.14
-0.0131 ( -8.56% ) 2.1M

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

Market Data


Insider Ownership Transactions

Total Amount Purchased: -874,488.00 | $ -122,340.87

Date Type Amount Purchased Purchaser
2023-11-03 Sale -437244.00 CONRAD HERBERT J
2023-11-03 Sale -437244.00 Ende Eric J

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Mar 22, 2024
8-k 8K-related 16 Feb 26, 2024
8-k 8K-related 16 Feb 20, 2024
8-k 8K-related 42 Jan 09, 2024
8-k 8K-related 14 Dec 27, 2023
8-k 8K-related 14 Dec 21, 2023
4 Insider transactions 1 Dec 15, 2023
4 Insider transactions 1 Dec 15, 2023
4 Insider transactions 1 Dec 15, 2023
4 Insider transactions 1 Dec 15, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.